Skip to main content
  • Graphic image showing scarring of a lung with the title Interstitial Lung Disease
    Interstitial Lung Disease
    Interstitial lung disease (ILD) is an umbrella term used for a large group of diseases that cause scarring (fibrosis) of the lungs. It affects millions of people globally. It is a serious condition that impacts mortality and quality of life of people affected by it.  ILD is different from COPD (Chronic Obstructive Pulmonary Disease)  
Submitted by PatientsEngage on 27 September 2024
ILD tests diagnosis

The diagnosis for Interstitial Lung Disease includes the following tests and examinations:

  1. History and Physical Examination:
    Your doctor may ask about the onset, severity, rate of worsening of symptoms, the family history, smoking and drug history, and the occupational and environmental exposure history. Smoking can cause and worsen ILDs.

    6-minute walk test: The doctor may perform a 6-minute walk test to assess the aerobic exercise capacity and thus the lung and heart function. The patient is asked to walk back and forth to a point for 6 minutes and to mention if there is any chest pain or difficulty in breathing. The heart rate, blood pressure, and oxygen saturation are then measured and compared to normal for the age to assess lung functioning.

    ILDs classically produce the “3Cs”: cough, clubbing of the nails, and coarse crackles on auscultation (action of listening to sounds from the heart or lungs).

    The examination further reveals any neurological issues, additional sounds like crepitations and rhonchi (sounds from the large airway that sound like gurgles or bubbling and may be heard during both inhalation and exhalation) in the lungs.

    Autoimmune diseases like sarcoidosis, rheumatoid arthritis elevate the risk of developing an ILD.
     

  2. Blood tests:
    Inflammatory markers like ESR, CRP, IL6 (acute phase inflammatory cytokine), KL-6 (a transmembrane mucoprotein which is secreted by injured alveolar cells and is a potential biomarker in multiple studies and found to correlate with the extent of fibrosis), Surfactant Protein-D (SPD). These help to assess the extent of lung inflammation, scarring, and related prognosis.

    Cell counts, as seen in the routine complete blood count (CBC), help to determine underlying causes and potential inflammation or infections if any.
     

  3. Pulmonary Function Test: This is used to demarcate whether the lung condition is restrictive or obstructive lung disease (for more info, read the article on Restrictive vs Obstructive lung disease). Since ILD is a restrictive disease, your Pulmonologist will look for the following patterns on your test report:
    • Decreased FVC (Forced vital capacity): The amount of air that can be forcibly exhaled from the lungs after inhaling as deeply as possible.
    • Decreased TLC (Total lung capacity): The total volume of air in the lungs after maximum possible inspiration.
    • FEV1 (Forced expiratory volume in 1st second): Usually shows a slight decrease or remains unchanged. It is the amount of air exhaled in the first second after a full inhalation.
    • Normal or increased ratio of FEV1 to FVC: A key pattern that pulmonologists look for in restrictive lung diseases.
    • Reduced DLCO (Diffusing capacity for carbon monoxide): The extent to which oxygen passes from the air sacs of the lungs into the blood.
       
  4. CT scan of the chest
    HRCT (High resolution computed tomography)
     
  5. Bronchoscopy or Lung Biopsy to view the tissue under microscope.

Questions to ask your doctor if you have been diagnosed with ILD:

  1. Understand the underlying cause of your ILD
  2. Discuss your treatment options.
  3. Possible rate of progression.
  4. What measures you can take to slow down the damage?
  5. The measure you can undertake to improve the quality of life.

     

Changed
21/Apr/2025

Stories

  • A middle aged man in a blue kurta and white pyjama sitting in front of a TV screen and text overlay on a blue strip My ILD Journey
    My Fight Against ILD: From Uncertainty to Positivity
    Tushar Kataria, 51 received a shocking diagnosis of Interstitial Lung Disease (ILD) 7 years ago. He shares his challenges of going through a lung transplant in 2018 and how his experience has changed his approach to health and life. How did you first find out that you had Interstitial Lung Disease (ILD)? In May 2016, I was on a vacation in Thailand with my family and some friends. I felt the first symptoms like breathlessness and running out of breath, but I did not feel the need to use oxygen…
  • Profile pic of Dr Sujeet Rajan and the text Lung Conditions and Scleroderma and logos of PatientsEngage and Scleroderma India
    Scleroderma and Lung Conditions Management
    Dr Sujeet Rajan, a highly reputed Pulmonologist spoke on ILD (Interstitial Lung Disease) and its management in Scleroderma at the Sclerocon e-conference held in June 2023. In simple terms, Dr Rajan explains what happens during ILD and Pulmonary Hypertension and benefits of preventive along with rehabilitative therapy in Scleroderma Lung disease. Systemic sclerosis or Scleroderma can affect the lung in several ways. What we need to worry about in Scleroderma is pulmonary hypertension,…
  • Profile pic of a young woman with scleroderma and Interstitial lung disease framed in a teal background
    Scleroderma Took A Toll On My Mental Wellbeing And Relationships
    Ashwini Nalhe, 33 from Nagpur  has been battling Scleroderma and a few other auto immune conditions for over 10 years now. These are rare conditions which people don’t know about, hence don’t understand. But this has torn Ashwini’s life apart in more senses than one,  and yet she has learnt to pick up the pieces and move on. Please tell us a bit about yourself and your condition. I am an engineer and also a lawyer by profession. I have been suffering from a set of autoimmune,…
  • स्क्लेरोडर्मा ने मेरी पहचान कैसे बदली
    42 साल की नीतू स्क्लेरोडर्मा होने से पहले एक सॉफ्टवेयर कंसलटेंट थीं, पर स्क्लेरोडर्मा ने उनके जीवन को और उनकी पहचान को बदल दिया। इस लेख में वे स्क्लेरोडर्मा होने के अनुभव और उस की चुनौतियों के बारे में बात करती हैं और साझा करती हैं कि कौन से जीवन शैली के बदलाव उनके लिए कारगर रहे हैं। वे अब स्क्लेरोडर्मा इंडिया की सह-संस्थापक हैं।  यह 2019 में किए गए एक इंटरव्यू का अनुवाद है | कृपया हमें अपनी स्थिति के बारे में कुछ बताएं, आपको निदान कब मिला और आपके शुरुआती लक्षण क्या थे? जनवरी 2006 में…
  • A woman in a yellow indian dress standing in front of plants after her lung transplant
    The Crooked Road To a Double Lung Transplant
    It all started with a black-out on a staircase. Neeta Seth, walks us through the crooked road to a diagnosis of Interstitial Lung Disease which kept worsening till she was advised a double lung transplant. A journey of treatment across 3 cities, the challenges of getting the transplant and post transplant care and rehabilitation. Going down the memory lane, I write about 13-14 years back. It was one of the usual morning schedules, when all the daily chores of the day were done. I was running up…
  • Profile pic of a woman with Scleroderma and Interstitial Lung Disease
    How Scleroderma Changed My Identity
    Neetu, 42 was a software consultant before the onset of Scleroderma transformed her life and identity. She describes her lived experience with Scleroderma, her challenges and the lifestyle changes that work for her. She is now co-founder Scleroderma India.  Please tell us a bit about your condition, when were you diagnosed, the early symptoms? In Jan 2006, I saw my fingers turning blue in extreme cold, but I ignored them. And during the same year, I started having breathing issues,…
  • Profile pic of a man with Idiopathic Pulmonary Fibrosis
    No One Understands The Complexity Of Pulmonary Fibrosis
    Dev Yadava, 72 from Mumbai was diagnosed with Idiopathic Pulmonary Fibrosis and in the 13 years since he has become an informed patient and continues to try all kinds of treatment options to deal with IPF. Please tell us a bit about your condition In Jan 2006 I was diagnosed with Idiopathic Pulmonary Fibrosis (IPF) - Non-specific Interstitial Pneumonitis (NSIP) which causes scarring (or fibrosis) of the lungs. It falls under the broad group of Interstitial Lung Diseases. It is idiopathic…